{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T21:20:38Z","timestamp":1757625638808,"version":"3.44.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National High Level Hospital Clinical Research Funding","award":["2022CR09"],"award-info":[{"award-number":["2022CR09"]}]},{"name":"National Science and Technology Major Projects for Major New Drugs Innovation and Development","award":["2017ZX09304028"],"award-info":[{"award-number":["2017ZX09304028"]}]},{"name":"CAMS Innovation Fund for Medical Science","award":["2019-I2M-5-046"],"award-info":[{"award-number":["2019-I2M-5-046"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04406-7","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T02:29:09Z","timestamp":1755829749000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Regional citrate anticoagulation for intermittent renal replacement therapy in critically ill patients: a retrospective case-control study"],"prefix":"10.1186","volume":"26","author":[{"given":"Tao","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qizhuang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,22]]},"reference":[{"key":"4406_CR1","doi-asserted-by":"publisher","unstructured":"Davenport A. What are the anticoagulation options for intermittent hemodialysis? Nat Rev Nephrol. 2011;7(9):499\u2013508. PMID: 21727925. https:\/\/doi.org\/10.1038\/nrneph.2011.88","DOI":"10.1038\/nrneph.2011.88"},{"issue":"6","key":"4406_CR2","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.kint.2016.09.009","volume":"90","author":"V Jha","year":"2016","unstructured":"Jha V, Arici M, Collins AJ, et al. Understanding kidney care needs and implementation strategies in low- and middle-income countries: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference. Kidney Int. 2016;90(6):1164\u201374. https:\/\/doi.org\/10.1016\/j.kint.2016.09.009","journal-title":"Kidney Int"},{"issue":"2","key":"4406_CR3","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s40620-024-02201-5","volume":"38","author":"F Di Mario","year":"2025","unstructured":"Di Mario F, Regolisti G, Fani F, et al. Sustained Low-Efficiency Dialysis (SLED) with regional citrate anticoagulation (RCA) and new dialysis equipment: a prospective study with serum citrate measurements and electrolyte monitoring. J Nephrol. 2025;38(2):473\u201380. https:\/\/doi.org\/10.1007\/s40620-024-02201-5","journal-title":"J Nephrol"},{"issue":"1","key":"4406_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13613-021-00803-x","volume":"11","author":"C Leroy","year":"2021","unstructured":"Leroy C, Pereira B, Soum E, et al. Regional citrate anticoagulation versus heparin for intermittent Hemodialysis in ICU patients. Ann Intensive Care. 2021;11(1):13. https:\/\/doi.org\/10.1186\/s13613-021-00803-x.","journal-title":"Ann Intensive Care"},{"issue":"11","key":"4406_CR5","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1631\/jzus.B2200082","volume":"23","author":"X Tang","year":"2022","unstructured":"Tang X, Chen D, Zhang L, et al. Regional citrate anticoagulation in high-risk bleeding patients during intermittent Hemodialysis. J Zhejiang Univ Sci B. 2022;23(11):931\u201342. https:\/\/doi.org\/10.1631\/jzus.B2200082.","journal-title":"J Zhejiang Univ Sci B"},{"issue":"2","key":"4406_CR6","doi-asserted-by":"publisher","first-page":"2387207","DOI":"10.1080\/0886022X.2024.2387207","volume":"46","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Ding D, Wang C, Lu J, Zhu Q, Ding F. Automated regional citrate anticoagulation system based on individualized dosing models in nonliver failure patients undergoing PIRRT therapy. Ren Fail. 2024;46(2):2387207. https:\/\/doi.org\/10.1080\/0886022X.2024.2387207.","journal-title":"Ren Fail"},{"issue":"12","key":"4406_CR7","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1007\/s00134-017-4924-8","volume":"43","author":"T Robert","year":"2017","unstructured":"Robert T, Bureau C, Lebourg L, et al. Regional citrate anticoagulation during intermittent Hemodialysis without calcium monitoring. Intensive Care Med. 2017;43(12):1927\u20138. https:\/\/doi.org\/10.1007\/s00134-017-4924-8.","journal-title":"Intensive Care Med"},{"issue":"1","key":"4406_CR8","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s11255-023-03677-z","volume":"56","author":"Y Fan","year":"2024","unstructured":"Fan Y, Wu F, Zou M, et al. An individualized regional citrate anticoagulation protocol for hemodialysis: a real-world retrospective study. Int Urol Nephrol. 2024;56(1):295\u2013302. https:\/\/doi.org\/10.1007\/s11255-023-03677-z.","journal-title":"Int Urol Nephrol"},{"issue":"4","key":"4406_CR9","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1053\/j.ajkd.2021.01.017","volume":"78","author":"H Rhee","year":"2021","unstructured":"Rhee H, Berenger B, Mehta RL, et al. Regional citrate anticoagulation for continuous kidney replacement therapy with calcium-containing solutions. Am J Kidney Dis. 2021;78(4):550\u2013e5591. https:\/\/doi.org\/10.1053\/j.ajkd.2021.01.017.","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"4406_CR10","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.2215\/CJN.00510113","volume":"8","author":"E Fiaccadori","year":"2013","unstructured":"Fiaccadori E, Regolisti G, Cademartiri C, et al. Citrate-based protocol for sustained low-efficiency Dialysis in AKI. Clin J Am Soc Nephrol. 2013;8(10):1670\u20138. https:\/\/doi.org\/10.2215\/CJN.00510113.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"4406_CR11","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1053\/ajkd.2002.30551","volume":"39","author":"P Evenepoel","year":"2002","unstructured":"Evenepoel P, Maes B, Vanwalleghem J, et al. Regional citrate anticoagulation using a conventional calcium-containing dialysate. Am J Kidney Dis. 2002;39(2):315\u201323. https:\/\/doi.org\/10.1053\/ajkd.2002.30551.","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"4406_CR12","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1177\/039139880803100507","volume":"31","author":"J Buturovic-Ponikvar","year":"2008","unstructured":"Buturovic-Ponikvar J, Cerne S, Gubensek J, et al. Calcium-free versus calcium-containing dialysate for regional citrate anticoagulation. Int J Artif Organs. 2008;31(5):418\u201324. https:\/\/doi.org\/10.1177\/039139880803100507.","journal-title":"Int J Artif Organs"},{"issue":"3","key":"4406_CR13","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1053\/j.ajkd.2004.12.002","volume":"45","author":"R Apsner","year":"2005","unstructured":"Apsner R, Buchmayer H, Gruber D, et al. Citrate for long-term hemodialysis: prospective study of 1009 consecutive high-flux treatments in 59 patients. Am J Kidney Dis. 2005;45(3):557\u201364. https:\/\/doi.org\/10.1053\/j.ajkd.2004.12.002.","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"4406_CR14","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1097\/CCM.0000000000002694","volume":"45","author":"S Faguer","year":"2017","unstructured":"Faguer S, Saint-Cricq M, Nogier MB, et al. Heparin-free intermittent Hemodialysis using calcium-free citrate dialysate in critically ill patients. Crit Care Med. 2017;45(11):1887\u201392. https:\/\/doi.org\/10.1097\/CCM.0000000000002694.","journal-title":"Crit Care Med"},{"key":"4406_CR15","doi-asserted-by":"publisher","unstructured":"Morabito S, Pistolesi V, Tritapepe L, Fiaccadori E. Implementation of a simplified regional citrate anticoagulation protocol for post-dilution continuous hemofiltration using a bicarbonate-buffered, calcium-containing replacement solution [published correction appears in Blood Purif. 2017;43(1\u20133):144]. Blood Purif. 2016;42(4):349\u2013355. https:\/\/doi.org\/10.1159\/000452755","DOI":"10.1159\/000452755"},{"issue":"12","key":"4406_CR16","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.2215\/CJN.01280214","volume":"9","author":"S Morabito","year":"2014","unstructured":"Morabito S, Pistolesi V, Tritapepe L, et al. Regional citrate anticoagulation for RRTs in critically ill patients with AKI. Clin J Am Soc Nephrol. 2014;9(12):2173\u201388. https:\/\/doi.org\/10.2215\/CJN.01280214.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5\u20136","key":"4406_CR17","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1159\/000530777","volume":"54","author":"J Liu","year":"2023","unstructured":"Liu J, Liu Z, Zhao T, Su T, Jin Q. Thromboelastography and traditional coagulation testing in Non-ICU-Admitted patients with acute kidney injury: an observational cohort study. Am J Nephrol. 2023;54(5\u20136):208\u201318. https:\/\/doi.org\/10.1159\/000530777.","journal-title":"Am J Nephrol"},{"issue":"1","key":"4406_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/kisup.2011.32","volume":"2","author":"KDIGO Clinical Practice Guideline for Acute Kidney Injury","year":"2012","unstructured":"KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl. 2012;2(1):19\u201336. https:\/\/doi.org\/10.1038\/kisup.2011.32.","journal-title":"Kidney Int Suppl"},{"issue":"5","key":"4406_CR19","first-page":"B113","volume":"1","author":"Hemostasis and thrombosis","year":"1994","unstructured":"Hemostasis and thrombosis. Curr Opin Hematol. 1994;1(5):B113\u201369.","journal-title":"Curr Opin Hematol"},{"issue":"3","key":"4406_CR20","doi-asserted-by":"publisher","first-page":"736","DOI":"10.2215\/CJN.03460807","volume":"3","author":"JA Clark","year":"2008","unstructured":"Clark JA, Schulman G, Golper TA. Safety and efficacy of regional citrate anticoagulation. Clin J Am Soc Nephrol. 2008;3(3):736\u201342. https:\/\/doi.org\/10.2215\/CJN.03460807.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"4406_CR21","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/cc9358","volume":"15","author":"HM Oudemans-van Straaten","year":"2011","unstructured":"Oudemans-van Straaten HM, Kellum JA, Bellomo R. Anticoagulation for continuous renal replacement therapy. Crit Care. 2011;15(1):202. https:\/\/doi.org\/10.1186\/cc9358.","journal-title":"Crit Care"},{"issue":"5","key":"4406_CR22","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.12.026","volume":"27","author":"K Meier","year":"2018","unstructured":"Meier K, Saenz DM, Torres GL, et al. Thrombelastography in renal dysfunction and intracerebral hemorrhage. J Stroke Cerebrovasc Dis. 2018;27(5):1350\u20136. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2017.12.026.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"6","key":"4406_CR23","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1177\/039139880903200603","volume":"32","author":"S Vaisman","year":"2009","unstructured":"Vaisman S, Kensey K, Cho YI. Hemodialysis and whole blood viscosity. Int J Artif Organs. 2009;32(6):329\u201335. https:\/\/doi.org\/10.1177\/039139880903200603.","journal-title":"Int J Artif Organs"},{"issue":"5","key":"4406_CR24","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1177\/039139888801100506","volume":"11","author":"J Wink","year":"1988","unstructured":"Wink J, Vaziri ND, Barker S, et al. Hemodialysis and blood viscosity. Int J Artif Organs. 1988;11(5):340\u20132.","journal-title":"Int J Artif Organs"},{"issue":"1","key":"4406_CR25","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1056\/NEJMoa1208500","volume":"368","author":"R Marchioli","year":"2013","unstructured":"Marchioli R, Finazzi G, Specchia G, et al. Cardiovascular events in polycythemia Vera. N Engl J Med. 2013;368(1):22\u201333. https:\/\/doi.org\/10.1056\/NEJMoa1208500.","journal-title":"N Engl J Med"},{"issue":"3","key":"4406_CR26","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/jcb.22308","volume":"108","author":"N Ogasawara","year":"2009","unstructured":"Ogasawara N, Oguro T, Sakabe T, et al. Hemoglobin and indoleamine 2,3-dioxygenase expression. J Cell Biochem. 2009;108(3):716\u201325. https:\/\/doi.org\/10.1002\/jcb.22308.","journal-title":"J Cell Biochem"},{"issue":"5","key":"4406_CR27","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s12630-019-01306-x","volume":"66","author":"G Alvarez","year":"2019","unstructured":"Alvarez G, Chrusch C, Hulme T, et al. Renal replacement therapy: a practical update. Can J Anaesth. 2019;66(5):593\u2013604. https:\/\/doi.org\/10.1007\/s12630-019-01306-x.","journal-title":"Can J Anaesth"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04406-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04406-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04406-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T18:59:33Z","timestamp":1757444373000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04406-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4406"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04406-7","relation":{},"ISSN":["1471-2369"],"issn-type":[{"type":"electronic","value":"1471-2369"}],"subject":[],"published":{"date-parts":[[2025,8,22]]},"assertion":[{"value":"9 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study complied with the Declaration of Helsinki. The study protocol was reviewed and approved by the Human Ethics Committee of the Peking University First Hospital (MR-11-23-021020). The need for informed consent was waived by the Human Ethics Committee of the Peking University First Hospital due to the retrospective nature of the study and the use of anonymized patient data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"480"}}